Financial insights of ICU

MyFinsight

For the quarter ending 2025-09-30, ICU made $183K in revenue. -$3,472K in net income. Net profit margin of -1897.27%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Income Statement	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Net revenue	183	338	293	68
Cost of goods sold	14	27	-	-
Gross profit	169	311	293	68
Research and development	1,850	1,037	2,431	2,336
General and administrative	1,898	1,030	1,684	2,188
Total operating expenses	3,748	2,067	4,115	4,524
Loss from operations	-3,579	-1,756	-3,822	-4,456
Interest expense	-	9	11	272
Interest income	107	45	48	58
Interest expense	0	-	-	-
Other financing costs	0	-	-	-
Change in fair value of convertible notes	0	-	-	-
Change in fair value of warrants liability	0	-16	-16	-192
Other financing costs	-	298	-	-
Change in fair value of convertible notes	-	0	-	-
Total other income (expense), net	107	-246	53	-22
Loss before provision for income taxes	-3,472	-2,002	-3,769	-4,478
Provision for income taxes	0	0	3	-
Net loss	-3,472	-2,002	-3,772	-4,478

Earnings per share, diluted	-	-0.18	-0.44	-1.1
Weighted average number of shares outstanding, diluted	-	11,329,517	8,617,932	4,086,871
Net loss per share of common stock, basic and diluted (in dollars per share)	-0.13	-0.18	-0.44	-1.1
Weighted-average shares outstanding, basic and diluted (in shares)	26,393,400	11,329,517	8,617,932	4,086,871